NanoHerb Therapeutics’ cubosome-based arthritis treatment receives FDA Fast Track status, while University of Milan research demonstrates 40% greater inflammation reduction than NSAIDs with zero...
Exploring herbal cubosomes as nanocarriers for anti-inflammatory compounds in osteoarthritis and rheumatoid arthritis treatment, highlighting reduced side effects and improved bioavailability. Herbal ...
